The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of melanoma immune profile (MIP) to predict RFS in stage II-III melanoma on adjuvant interferon trial (E1697).
 
Yvonne Saenger
Consulting or Advisory Role - Replimune
Other Relationship - Research Funding (Inst)
 
Tianyun Jiang
No Relationships to Disclose
 
Gerardo Espinoza
No Relationships to Disclose
 
Yadriel Bracero
No Relationships to Disclose
 
Divya Kenchappa
No Relationships to Disclose
 
Ajay Singh
No Relationships to Disclose
 
Lawrence Leung
No Relationships to Disclose
 
Nailya Khalizova
No Relationships to Disclose
 
John Krolewski
No Relationships to Disclose
 
Sandra Lee
Stock and Other Ownership Interests - ImmunityBio (I)
Consulting or Advisory Role - Roche/Genentech
 
John Kirkwood
Consulting or Advisory Role - Ankyra Therapeutics; AXIO Research; Boxer Capital; Bristol Myers Squibb; Daiichi Sankyo; Engage Health Media; GE Healthcare; Intellisphere; IQVIA; Istari; Lumira Capital Investment Management; Lytix Biopharma; Merck; Mural Oncology; Natera; Novartis; OncoCyte; Pfizer; Piper Sandler; PyrOjas Corporation; Regeneron; Replimune; Scitaris GmbH & Co. KG; Sun Pharma; Syntaxx Communications; Takeda; Valar Labs; Zola Therapeutics
Research Funding - Ankyra Therapeutics (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); Harbour BioMed (Inst); Immunocore (Inst); Immvira (Inst); Iovance Biotherapeutics (Inst); Lion Biotechnologies (Inst); Lytix Biopharma (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst); Takeda (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lumanity; Regeneron
 
Jee-Young Moon
No Relationships to Disclose
 
Basil Horst
No Relationships to Disclose
 
Kent Nastiuk
No Relationships to Disclose
 
Rui Chang
No Relationships to Disclose